NIH-funded research R01 grant

THC and CBD for opioid addiction and chronic pain

Official title: Combination of THC and CBD as a Novel Treatment for Co-Occurring Opioid Addiction and Chronic Pain

Funded at Yale University · NIH-11371353 · Data updated 2026-11-12

This project seeks to reduce both chronic pain and opioid cravings in people with opioid use disorder who are receiving opioid agonist therapy by using a combination of THC and CBD.

More Chronic Pain research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startMay 1, 2024
Project endFebruary 28, 2028
Funding year2026
Award (this year)$454,523
NIH project number5R01DA060066-03
Project IDNIH-11371353 on NIH RePORTER

Who could benefit from this research

Could help

Adults with opioid use disorder who also have chronic pain and are currently receiving opioid agonist therapy (for example, methadone or buprenorphine) would be the ideal candidates.

Less likely to help

People without opioid use disorder, those not on opioid agonist therapy, pregnant individuals, or anyone with medical or psychiatric contraindications to cannabinoid use may not benefit or be eligible.

What this research studies

If you join, you'll receive combined doses of THC and CBD during supervised lab visits while staying on your usual opioid agonist medication. Researchers will measure your pain sensitivity with standardized quantitative sensory tests and track your opioid cravings using a visual cue task. The team wants to see whether CBD can lower cue-induced craving and whether adding THC provides extra pain relief while CBD may limit THC’s side effects. Sessions will be monitored for safety and tolerability at Yale.

Why it matters

Potential benefit: If successful, this approach could offer a single treatment that eases chronic pain and reduces opioid craving, potentially improving recovery and lowering overdose risk.

How similar studies have gone: Previous studies suggest THC can reduce pain and CBD can reduce cue-induced opioid craving, but the combined effects in people with both OUD and chronic pain are largely untested.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: De Aquino, Joao Paulo — Yale University
  • Study coordinator: De Aquino, Joao Paulo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.